Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Sales

Burning Rock Biotech (BNR) EBIT Margin: 2020-2025

Historic EBIT Margin for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to 12.22%.

  • Burning Rock Biotech's EBIT Margin rose 2174.00% to 12.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 21.49%, marking a year-over-year increase of 6561.00%. This contributed to the annual value of 69.32% for FY2024, which is 5522.00% up from last year.
  • According to the latest figures from Q3 2025, Burning Rock Biotech's EBIT Margin is 12.22%, which was down 57.10% from 7.78% recorded in Q2 2025.
  • Burning Rock Biotech's EBIT Margin's 5-year high stood at 7.78% during Q2 2025, with a 5-year trough of 203.45% in Q2 2022.
  • For the 3-year period, Burning Rock Biotech's EBIT Margin averaged around 73.73%, with its median value being 81.95% (2024).
  • Its EBIT Margin has fluctuated over the past 5 years, first crashed by 5,523bps in 2021, then skyrocketed by 11,293bps in 2023.
  • Over the past 5 years, Burning Rock Biotech's EBIT Margin (MRQ) stood at 170.61% in 2021, then rose by 9bps to 155.21% in 2022, then grew by 12bps to 135.95% in 2023, then skyrocketed by 53bps to 64.21% in 2024, then surged by 81bps to 12.22% in 2025.
  • Its EBIT Margin was 12.22% in Q3 2025, compared to 7.78% in Q2 2025 and 11.41% in Q1 2025.